SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-012355
Filing Date
2024-02-08
Accepted
2024-02-08 17:07:33
Documents
15
Period of Report
2024-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245678d1_8k.htm   iXBRL 8-K 28033
  Complete submission text file 0001104659-24-012355.txt   246855

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gfor-20240204.xsd EX-101.SCH 3272
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gfor-20240204_def.xml EX-101.DEF 26915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gfor-20240204_lab.xml EX-101.LAB 36508
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gfor-20240204_pre.xml EX-101.PRE 25539
16 EXTRACTED XBRL INSTANCE DOCUMENT tm245678d1_8k_htm.xml XML 5369
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 24610061
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)